Zimbabwe has declined a major US healthcare agreement valued at 367 million US dollars (£272m) spanning five years over Washington's insistence on sensitive information.
The decision was revealed after a government memo dated December was leaked, indicating that President Emmerson Mnangagwa believed the deal was "unbalanced".
An official spokesman later explained that the United States was seeking genetic material for scientific study and commercial gain but was unwilling to guarantee the benefits from any future treatments.
"We will now turn to the difficult and regrettable task of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for continued negotiations to reach a deal acceptable to all parties so the nation's vital HIV programme can be sustained.
Broader Context
This development follows a similar situation in Kenya, where a court suspended a related deal with the US after legal challenges were filed about the security of Kenyans' medical information.
After resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump argued its spending was "inefficient" and his administration was seeking direct bilateral agreements to enhance transparency and responsibility.
Based on statements, Sixteen nations in Africa have so far agreed to these new agreements, representing more than $18.3bn in committed funds.
Details of the Rejected Deal
The money for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment via American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana argued the arrangement was "unfair".
"Zimbabwe was being asked to surrender its biological resources and data for a long time, with no equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"Put simply, our country would provide the raw materials for medical research without any certainty that the end products would be accessible to our people should a future disease outbreak emerge."
Sovereignty and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining systems already established via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential pandemics.
"This system is intended to guarantee that when a country provides its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."
The government's concerns over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to further dialogue with our US partners on how subsequent co-operation could be arranged in a manner that honours the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but suggested that negotiations need to persist given that a large portion of the country's HIV programmes depended on external financing.
"In cases where technical issues exist, including those relating to data governance or agreement terms, these can frequently be resolved through technical clarification and negotiated safeguards," the group said.
This impasse emphasises the complex debate between accepting much-needed international aid and safeguarding a country's data in an increasingly interconnected world.